Producing simplified overviews of clinical studies for the general public isn’t as straightforward a proposition as it might seem.

Is the Russian pharmaceutical market on course for rapid growth or will it devolve into a market plagued by staleness and drug shortages?

Heralded as a pivotal moment in science, CRISPR is the game-changing human gene editing tool that has scientists the world over excited about its potential to easily re-engineer biological systems an...

With advancements in the biomedical device technology industry, more efficient delivery systems capable of delivering finer particles into the lungs have started to show on the market and in hospit...

At Adents’ recent serialization innovation summit we spoke to Andrew Whytock, Head of Digitalization and Innovation, Pharmaceutical Business at Siemens about digitization and how it’s influencing the...

An online series featuring live interactive webinars, on-demand webinars, whitepapers, infographics, commentary articles and interviews all focusing on supply chain excellence with temperature sensiti...

Download this eBook to discover the key outsourcing trends impacting today's pharma and biotech industries.

SmartLab Global Academy is a complementary online series featuring live interactive webinars and on-demnd sessions with hand-picked case studies by pharmaceutical industry experts and thought leaders...

Tatjana Crnogorac-Jurcevic, Reader Centre for Molecular Oncology, Queen Mary University of London examines a new test that can detect eight types of cancer in a drop of blood.

Recent research has determined that thrombolysis is still the best treatment for acute stroke patients.

Doctors are people too, seeking engagement and enjoyment in their day-to-day lives. And pharmaceutical companies are taking notice.

All signs point to growth in the year ahead for the medical device sector.

Researchers have uncovered a new drug candidate that could relieve millions of people who are underserved by current asthma treatments.

Capturing data which is accurate and timely is one of the critical elements that predicates a successfully run clinical trial.

As pharma looks to provide personalized medicines, the industry has no option but to better inform the drug discovery and development process.

Alongside professionals from Microsoft, experts from across the globe presented insights on how digitalization is changing medicine.

Similar to new Hollywood feature Rampage, a recent study has urged the life sciences industry not to underestimate the dangers that could hide within CRISPR Cas9.

Recently Pharma IQ’s YouTube Channel was voted into the Top 30 pharma YouTube channels.

To fast-track the development of innovative medicines, a biotech start-up is opening access to its extensive genomic and bioinformatics resources.

Pooja Phogat, regulation and compliance expert at Kinapse, provides insight on the most effective approaches that reflect the spirit of the Policy

Human Genetics Scientist, Joyce El Hokayem examines where the digital era is taking today’s clinical trials.